Belimumab (Benlysta) has been FDA approved for use in pediatric patients with active lupus nephritis who are receiving s
Tweet Content
Belimumab (Benlysta) has been FDA approved for use in pediatric patients with active lupus nephritis who are receiving standard lupus therapy. The approval in kids is for the IV formulation only; SC belimumab is for SLE and LN in adults https://t.co/TKyNDwIUQH https://t.co/6VaMOMfwYi
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off